This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Ananthakrishnan Sankaranarayanan: Innovator in Potassium Channel Inhibition
Introduction
Ananthakrishnan Sankaranarayanan is a notable inventor based in Davis, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target potassium channels. His work has implications for treating various autoimmune diseases.
Latest Patents
Sankaranarayanan holds 2 patents, with his latest inventions focusing on 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage-gated Kv1.3 potassium channel. These compounds are designed to treat diseases or disorders in both human and animal subjects. They inhibit potassium channels, including the Kv1.3 channel, and some therapeutic effects may be attributed to this inhibition. Notably, these compounds exhibit selectivity for certain potassium channels, such as Kv1.3, over others like Kv1.5.
Career Highlights
Ananthakrishnan Sankaranarayanan is affiliated with the University of California, where he continues to advance research in his field. His innovative work has garnered attention for its potential to improve treatment options for autoimmune diseases.
Collaborations
Sankaranarayanan has collaborated with esteemed colleagues, including Heike Wulff and Wolfram Haensel, to further his research endeavors. Their combined expertise enhances the impact of their work in potassium channel inhibition.
Conclusion
Ananthakrishnan Sankaranarayanan is a prominent inventor whose research on potassium channel inhibitors holds promise for treating autoimmune diseases. His contributions to medicinal chemistry are noteworthy and continue to influence the field.